In a previous study, our group has shown, in a limited number of cases, that COPD-related LUADs presented morphological and molecular aspects of lower aggressiveness, in terms of prevalent lepidic histological pattern, lower proliferation rate and less frequent KRAS mutation [29]. This evidence concerns the gene KRAS and chronic obstructive pulmonary disease.